# | Title | Journal | Year | Citations |
---|
1 | Methodological quality and synthesis of case series and case reports | BMJ Evidence-Based Medicine | 2018 | 1,337 |
2 | Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis | BMJ Evidence-Based Medicine | 2021 | 405 |
3 | Overdiagnosis: what it is and what it isn’t | BMJ Evidence-Based Medicine | 2018 | 191 |
4 | COVID-19 and the US response: accelerating health inequities | BMJ Evidence-Based Medicine | 2021 | 149 |
5 | Evidence-based practice education for healthcare professions: an expert view | BMJ Evidence-Based Medicine | 2019 | 142 |
6 | The effect of publication bias magnitude and direction on the certainty in evidence | BMJ Evidence-Based Medicine | 2018 | 130 |
7 | Is there a smoker’s paradox in COVID-19? | BMJ Evidence-Based Medicine | 2021 | 110 |
8 | Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil | BMJ Evidence-Based Medicine | 2021 | 107 |
9 | Catalogue of bias: publication bias | BMJ Evidence-Based Medicine | 2019 | 102 |
10 | Catalogue of bias: attrition bias | BMJ Evidence-Based Medicine | 2018 | 101 |
11 | Redefining rapid reviews: a flexible framework for restricted systematic reviews | BMJ Evidence-Based Medicine | 2018 | 90 |
12 | Should antidepressants be used for major depressive disorder? | BMJ Evidence-Based Medicine | 2020 | 79 |
13 | Effectiveness of tests to detect the presence of SARS-CoV-2 virus, and antibodies to SARS-CoV-2, to inform COVID-19 diagnosis: a rapid systematic review | BMJ Evidence-Based Medicine | 2022 | 78 |
14 | Network meta-analysis: the highest level of medical evidence? | BMJ Evidence-Based Medicine | 2018 | 67 |
15 | Catalogue of bias: observer bias | BMJ Evidence-Based Medicine | 2018 | 61 |
16 | Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision making | BMJ Evidence-Based Medicine | 2022 | 52 |
17 | Reflections on the history of systematic reviews | BMJ Evidence-Based Medicine | 2018 | 51 |
18 | Asthma and COVID-19: review of evidence on risks and management considerations | BMJ Evidence-Based Medicine | 2021 | 50 |
19 | Effectiveness of honey for symptomatic relief in upper respiratory tract infections: a systematic review and meta-analysis | BMJ Evidence-Based Medicine | 2021 | 49 |
20 | Key Concepts for Informed Health Choices: a framework for helping people learn how to assess treatment claims and make informed choices | BMJ Evidence-Based Medicine | 2018 | 48 |
21 | Critical appraisal of qualitative research: necessity, partialities and the issue of bias | BMJ Evidence-Based Medicine | 2020 | 46 |
22 | Patient-reported outcome measures (PROMs) as proof of treatment efficacy | BMJ Evidence-Based Medicine | 2022 | 46 |
23 | External validity, generalisability, applicability and directness: a brief primer | BMJ Evidence-Based Medicine | 2018 | 45 |
24 | The Cochrane HPV vaccine review was incomplete and ignored important evidence of bias | BMJ Evidence-Based Medicine | 2018 | 45 |
25 | Different knowledge, different styles of reasoning: a challenge for guideline development | BMJ Evidence-Based Medicine | 2018 | 44 |
26 | Adapt or die: how the pandemic made the shift from EBM to EBM+ more urgent | BMJ Evidence-Based Medicine | 2022 | 42 |
27 | Evaluation of spin in abstracts of papers in psychiatry and psychology journals | BMJ Evidence-Based Medicine | 2020 | 41 |
28 | Maternal caffeine consumption and pregnancy outcomes: a narrative review with implications for advice to mothers and mothers-to-be | BMJ Evidence-Based Medicine | 2021 | 41 |
29 | Open-label placebo clinical trials: is it the rationale, the interaction or the pill? | BMJ Evidence-Based Medicine | 2020 | 40 |
30 | Misleading clinical evidence and systematic reviews on ivermectin for COVID-19 | BMJ Evidence-Based Medicine | 2022 | 40 |
31 | Transparency of COVID-19 vaccine trials: decisions without data | BMJ Evidence-Based Medicine | 2022 | 39 |
32 | Shared decision is the only outcome that matters when it comes to evaluating evidence-based practice | BMJ Evidence-Based Medicine | 2018 | 37 |
33 | Reforming disease definitions: a new primary care led, people-centred approach | BMJ Evidence-Based Medicine | 2019 | 36 |
34 | Characteristics, quality and volume of the first 5 months of the COVID-19 evidence synthesis infodemic: a meta-research study | BMJ Evidence-Based Medicine | 2022 | 35 |
35 | Blinding in randomised clinical trials of psychological interventions: a retrospective study of published trial reports | BMJ Evidence-Based Medicine | 2021 | 34 |
36 | The magnitude of small-study effects in the Cochrane Database of Systematic Reviews: an empirical study of nearly 30 000 meta-analyses | BMJ Evidence-Based Medicine | 2020 | 33 |
37 | Summarising good practice guidelines for data extraction for systematic reviews and meta-analysis | BMJ Evidence-Based Medicine | 2021 | 33 |
38 | Verification bias | BMJ Evidence-Based Medicine | 2018 | 31 |
39 | Estimates of the minimal important difference to evaluate the clinical significance of antidepressants in the acute treatment of moderate-to-severe depression | BMJ Evidence-Based Medicine | 2022 | 30 |
40 | Sacubitril, valsartan and SARS-CoV-2 | BMJ Evidence-Based Medicine | 2021 | 29 |
41 | Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK? | BMJ Evidence-Based Medicine | 2022 | 28 |
42 | Fat or fiction: the diet-heart hypothesis | BMJ Evidence-Based Medicine | 2021 | 28 |
43 | Digital aripiprazole or digital evergreening? A systematic review of the evidence and its dissemination in the scientific literature and in the media | BMJ Evidence-Based Medicine | 2019 | 27 |
44 | Limited engagement with transparent and open science standards in the policies of pain journals: a cross-sectional evaluation | BMJ Evidence-Based Medicine | 2021 | 27 |
45 | Medical scientists and philosophers worldwide appeal to EBM to expand the notion of ‘evidence’ | BMJ Evidence-Based Medicine | 2020 | 26 |
46 | HOSPITAL Score, LACE Index and LACE+ Index as predictors of 30-day readmission in patients with heart failure | BMJ Evidence-Based Medicine | 2020 | 25 |
47 | How effective are ‘age’ tools at changing patient behaviour? A rapid review | BMJ Evidence-Based Medicine | 2020 | 24 |
48 | Catalogue of bias: allocation bias | BMJ Evidence-Based Medicine | 2018 | 23 |
49 | When to include clinical study reports and regulatory documents in systematic reviews | BMJ Evidence-Based Medicine | 2018 | 23 |
50 | Assessing assumptions for statistical analyses in randomised clinical trials | BMJ Evidence-Based Medicine | 2019 | 23 |